Skip to main content

Featured

More HZMB private car quotas set

The governments of Hong Kong and Macau have agreed to increase the regular quotas for Hong Kong cross-boundary non-commercial private cars using the Hong Kong-Zhuhai-Macao Bridge to Macau, the Transport Department announced today.   The decision was made to enhance traffic flow between Hong Kong and Macau, better utilising the bridge, the department said.   It will increase the Hong Kong quota by 1,000, following the earlier quota allocation of 1,800 for Hong Kong.   The additional quota will be distributed in two phases from the second quarter.   Half of the additional 1,000 quota allocations is for company applicants and the other half is for individual applicants. The quotas are valid for no more than three years. The eligibility criteria of quota applications remains the same.   Private cars allocated with Hong Kong quotas will be permitted to access the city of Macau multiple times using the bridge.   The Hong Kong quota allotments will be re-allocated upon expiry thro

Vaccine protection under scrutiny

Secretary for Food & Health Prof Sophia Chan said experts of the Joint Scientific Committee under the Centre for Health Protection will monitor the situation of new COVID-19 variants and review the data on the protection of various vaccines against such variants.   Speaking to the media after attending a radio programme today, Prof Chan noted that the committee has given information about the protection of different vaccines against the new variants.   She said: “According to the experts, the BioNtech vaccine is able to protect against some of the variants of concern. For the Sinovac vaccine, they are still waiting for further information from Sinovac.   “The experts will continue to monitor the situation and review any data provided to the Department of Health.”   For the vaccine produced by AstraZeneca, which the Government has signed an advance purchase agreement with, Prof Chan said the Government is aware of the news reports concerning the vaccine in different countries.   “We also notice there is news from the World Health Organization and also some countries most recently said that all the adverse effects are not related to or do not have a direct relationship with the vaccination of the AstraZeneca vaccine.   “We will continue to monitor the situation and the Department of Health has asked the manufacturer for further information.”   She explained that regarding the procedure, the manufacturer must first apply for approval for use in Hong Kong and the Advisory Panel on COVID-19 Vaccines will review the data before it recommends it for authorisation by the Government.   Such a process has not yet started, Prof Chan added.
http://dlvr.it/Rw1Hth

Popular Posts